Explore how cutting-edge proteomics tools are shaping clinical oncology strategies in Anti-body Drug Conjugate (ADC) development programmes. This webinar featured expert insights from Professor Roger Reddel, Professor Paul Waring and Dr Jia Liu, attendees from across pharmaceutical/ biotech/ clinical and research, and an engaging Q&A session.